1. Search Result
Search Result
Isoforms Recommended: AnxA1
Results for "

ANXA1

" in MedChemExpress (MCE) Product Catalog:

10

Inhibitors & Agonists

3

Peptides

2

Inhibitory Antibodies

4

Recombinant Proteins

3

Antibodies

3

Oligonucleotides

Targets Recommended:
Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-P10412

    ANXA1-derived 11 amino acid-long peptide

    Ephrin Receptor Annexin A Cancer
    A11 (ANXA1-derived 11 amino acid-long peptide) is a ANXA1-EphA2 interaction-blocking peptide. A11 reduces ANXA1 bound to EphA2 and increases Cbl (the E3 ubiquitin ligase of EphA2) bound to EphA2. A11 inhibits the proliferation, migration and invasion of nasopharyngeal carcinoma cells. A11 inhibits angiogenesis. A11 can be used in studies related to nasopharyngeal carcinoma [1].
    A11
  • HY-P10275

    Apoptosis Neurological Disease
    Tat-NTS peptide is a cell-penetrating peptide with neuroprotective effects. Tat-NTS peptide can specifically inhibit the nuclear translocation of ANXA1 and reduce neuronal apoptosis in ischemic areas. Moreover, Tat-NTS peptide can reduce the volume of cerebral ischemic infarction and can be used in the research of ischemic stroke [1].
    Tat-NTS peptide
  • HY-RS00757

    Small Interfering RNA (siRNA) Others

    ANXA1 Human Pre-designed siRNA Set A contains three designed siRNAs for ANXA1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    ANXA1 Human Pre-designed siRNA Set A
    ANXA1 Human Pre-designed siRNA Set A
  • HY-RS16647

    Small Interfering RNA (siRNA) Others

    Anxa1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Anxa1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Anxa1 Mouse Pre-designed siRNA Set A
    Anxa1 Mouse Pre-designed siRNA Set A
  • HY-P10412A

    ANXA1-derived 11 amino acid-long peptide acetate

    Ephrin Receptor Annexin A Cancer
    A11 (ANXA1-derived 11 amino acid-long peptide) acetate is a ANXA1-EphA2 interaction-blocking peptide. A11 acetate reduces ANXA1 bound to EphA2 and increases Cbl (the E3 ubiquitin ligase of EphA2) bound to EphA2. A11 acetate inhibits the proliferation, migration and invasion of nasopharyngeal carcinoma cells. A11 acetate inhibits angiogenesis. A11 acetate can be used in studies related to nasopharyngeal carcinoma [1].
    A11 acetate
  • HY-RS23081

    Small Interfering RNA (siRNA) Others

    Anxa1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Anxa1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Anxa1 Rat Pre-designed siRNA Set A
    Anxa1 Rat Pre-designed siRNA Set A
  • HY-P11491

    Formyl Peptide Receptor (FPR) Reactive Oxygen Species (ROS) Inflammation/Immunology
    Ac2-26 (mouse) is the N-terminal active peptide of Annexin A1 (AnxA1). Ac2-26 (mouse) regulates the inflammatory response by modulating the formyl peptide receptor (FPR) signaling pathway. Ac2-26 (mouse) can promote the release of chemokines and inhibit the production of ROS. Ac2-26 (mouse) can be used for the research of inflammation, such as rheumatoid arthritis [1].
    Ac2-26 (mouse)
  • HY-P992100

    Annexin A Cancer
    Amesotatug is a humanized monoclonal antibody and ANXA1 binder. Amesotatug binds to Homo sapiens ANXA1 and exhibits antineoplastic activity. Amesotatug can be used for the research of cancer [1].
    Amesotatug
  • HY-P991864

    MDX-124

    Formyl Peptide Receptor (FPR) Cancer
    Annexuzlimab is a humanised IgG1 monoclonal antibody which specifically binds to ANXA1 disrupting its interaction with formyl peptide receptors 1 and 2 (FPR1/2). Annexuzlimab arrests cell cycle progression with cancer cells accumulating in the G1 phase. Annexuzlimab targets secreted ANXA1, preventing FPR1/2 activation and reducing cancer progression. Annexuzlimab can be used for the research of triple negative breast cancer, pancreatic cancer and osteosarcoma [1] .
    Annexuzlimab
  • HY-16254

    Annexin A Cardiovascular Disease
    Hydrocortamate hydrochloride is a broad-spectrum immunosuppressant. Hydrocortamate hydrochloride has been identified as a potential inhibitor of T cell proliferation in ischemia-reperfusion injury (IRI), specifically targeting the ANXA1 gene. Hydrocortamate hydrochloride can be used in inflammation research [1].
    Hydrocortamate hydrochloride

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: